To establish whether engineered human B cells can take up antigen from the membrane of tumor cells, we labeled the membranes of CLDN6-expressing tumor cell lines (PA-1, OVCAR3, and OV90) and a CLDN6-negative tumor line (A549) with a membrane intercalating dye. Here, CLDN6 is linked to neoplasm.